Displaying items 109-120 of 147
» View wsbt.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-13
•
Next >
-
Massive malaria vaccine trial has begun in Africa
Booster ShotsA massive Phase 3 trial of a malaria vaccine is now underway in Africa, with 5,000 children enrolled already out of a target population of 16,000. If results are favorable, marketing approval could be sought as early as 2012, making...... -
FDA commissioner reassures doctors about swine flu vaccine safety
Booster ShotsDr. Margaret A. Hamburg, commissioner of the Food and Drug Administration, sent a letter to all U.S. physicians today thanking them for their help in combating the pandemic H1N1 influenza virus and reassuring them about the safety of the vaccine...... -
Swine flu seems to be trailing off -- for now, at least
Booster ShotsThe current wave of pandemic H1N1 influenza infections is trailing off a little, the Centers for Disease Control and Prevention said this morning, and other indicators seem to confirm that diagnosis. In particular, the numbers of prescriptions written for... -
Nearly 8,000 H1N1 flu deaths worldwide, WHO says
Booster ShotsAt least 7,826 people worldwide have died from laboratory-confirmed cases of pandemic H1N1 influenza, an increase of more than 1,000 in the last week, but the actual number is probably much larger than that, the World Health Organization said today....... -
'Listening to Prozac' author feels 'vindicated' by new antidepressant study
Booster ShotsPeter D. Kramer, the psychiatrist and author of the path-breaking 1993 book "Listening to Prozac," said in an interview today that he felt "vindicated" by a newly published study ("Personality Change During Depression Treatment," by Tony Z. Tang et al)...... -
The Morning Fix: Drug company really wants to produce! Warner Bros. wants you to wait. Justice to review Comcast-NBC. Avatar heading to FX
Company TownAfter the coffee. Before deciding if it'll be Alabama or Texas. (Hint: Texas) Warner Bros. wants you to wait. Hoping to boost DVD sales, Warner Bros. struck a deal with Netflix in which the online-DVD-rental powerhouse will agree to wait...... -
Consumer Confidential: Chevron profits, Wells penalty fee, nurdle rights
Money & CompanyHere's your frosted-flakes Friday roundup of consumer news from around the Web: -- Well, all I can say is, "Thank goodness!" Our friends at Chevron are pleased to report that their quarterly profit more than tripled to $5.4 billion from...... -
For Diabetes Drug Avandia, Bad News Continues
Los Angeles TimesThe diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....Tags: Avandia (drug), Trials, Health, Cleveland Clinic, Government Health Care
-
Glaxo Settles Avandia Lawsuits for $460 Million
GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said.
Glaxo, the U.K.'s biggest drugmaker, agreed to...Tags: Avandia (drug), Health, Trials, Lawyers, Companies and Corporations
-
The Avandia Dilemma
Staff WriterThe arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...Tags: Avandia (drug), Health, Diseases and Illnesses, Washington (U.S. state), Medical Research
-
FDA: Avandia Should Stay With Restrictions
Los Angeles TimesFaced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...Tags: Avandia (drug), Health, Cleveland Clinic, Health and Medical Professionals, Los Angeles
-
Protein Sciences Corp. In Meriden Gets Federal OK To Begin Clinical Trials Of Swine Flu Vaccine
egershon@courant.comProtein Sciences Corp. said Thursday that it has received federal approval to conduct clinical trials of its H1N1 swine flu vaccine, an essential step in the drug approval process. Chief Executive Dan Adams said the company has been cleared by the Food...Tags: U.S. Centers for Disease Control and Prevention, Trials, Health, Meriden, Companies and Corporations
Nov 4, 2009
| Los Angeles Times
Nov 10, 2009
| Los Angeles Times
Nov 20, 2009
| Los Angeles Times
Nov 27, 2009
| Los Angeles Times
Dec 8, 2009
| Los Angeles Times
Jan 7, 2010
| Los Angeles Times
Jul 30, 2010
| Los Angeles Times
Jun 29, 2010
|Story| Los Angeles Times
Jul 13, 2010
|Story| Los Angeles Times
Jun 30, 2010
|Story| Health Portal
Jul 15, 2010
|Story| Los Angeles Times
Aug 21, 2009
|Story| Hartford Courant
Original site for GlaxoSmithKline PLC topic gallery.